RB1 and endometrial cancer: (51) successfully established a progesterone-resistant endometrial cancer cell line, revealing that resistance may be attributed to an imbalance of progesterone receptor isoforms, specifically, the downregulation of PR-A mRNA, upregulation of PR-B/PR-A mRNA, and increased expression of PR proteins expression.